Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-05-17

FDA Approved: CLOPIDOGREL — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva's generic clopidogrel; an antiplatelet agent used to reduce cardiovascular events in patients with acute coronary syndrome, a history of myoca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOPIDOGREL (CLOPIDOGREL)

Snippet

ORIG AP for CLOPIDOGREL (CLOPIDOGREL)